These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32705357)

  • 21. Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease.
    Mucalo L; Field JJ; Highland J; Khan H; Hankins JS; Singh A; Brandow AM
    Blood Adv; 2023 Jul; 7(14):3658-3665. PubMed ID: 37058480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain-measurement tools in sickle cell disease: where are we now?
    Darbari DS; Brandow AM
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):534-541. PubMed ID: 29222302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic neuropathic pain in SCI: evaluation and treatment.
    Felix ER
    Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):545-71, viii. PubMed ID: 25064788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing the management of chronic pain in sickle cell disease.
    Osunkwo I; O'Connor HF; Saah E
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):562-569. PubMed ID: 33275672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain.
    Williams H; Tanabe P
    J Pain Symptom Manage; 2016 Feb; 51(2):163-77. PubMed ID: 26596876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle cell disease pain management and the medical home.
    Raphael JL; Oyeku SO
    Hematology Am Soc Hematol Educ Program; 2013; 2013():433-8. PubMed ID: 24319216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
    Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
    Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pain management in sickle cell disease].
    Rasche T; Emmert D; Seidel H; Sellin J; Conrad R; Mücke M
    Schmerz; 2020 Jun; 34(3):285-296. PubMed ID: 32367470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient?
    Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R
    Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unmet needs in the management of neuropathic pain.
    Harden N; Cohen M
    J Pain Symptom Manage; 2003 May; 25(5 Suppl):S12-7. PubMed ID: 12694988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults.
    Antunes FD; Propheta VGS; Vasconcelos HA; Cipolotti R
    Ann Hematol; 2017 Jul; 96(7):1121-1125. PubMed ID: 28361297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sickle-cell pain: advances in epidemiology and etiology.
    Smith WR; Scherer M
    Hematology Am Soc Hematol Educ Program; 2010; 2010():409-15. PubMed ID: 21239827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.
    Sagi V; Argueta DA; Kiven S; Gupta K
    Complement Ther Med; 2020 Jun; 51():102394. PubMed ID: 32507420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stigma and Pain in Adolescents Hospitalized for Sickle Cell Vasoocclusive Pain Episodes.
    Martin SR; Cohen LL; Mougianis I; Griffin A; Sil S; Dampier C
    Clin J Pain; 2018 May; 34(5):438-444. PubMed ID: 28877143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acupuncture for pain management in children with sickle cell disease.
    Mahmood LA; Reece-Stremtan S; Idiokitas R; Martin B; Margulies S; Hardy SJ; Bost JE; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102287. PubMed ID: 32147045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Sickle Cell Pain Using Pregabalin: A Pilot Study.
    Schlaeger JM; Molokie RE; Yao Y; Suarez ML; Golembiewski J; Wilkie DJ; Votta-Velis G
    Pain Manag Nurs; 2017 Dec; 18(6):391-400. PubMed ID: 28843636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain management of sickle cell disease.
    Ballas SK
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):785-802, v. PubMed ID: 16214644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of sickle cell pain.
    Richard RE
    Curr Pain Headache Rep; 2009 Aug; 13(4):295-7. PubMed ID: 19586593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.